Trial intelligence / Profile preview

Venous versus inhalational general anesthesia and risk of acute kidney injury after laparoscopic bariatric surgery

RBR-8wt2fyPhase 4Completed

Sponsor
Adriano Teixeira Fernandes
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of propofol and sevoflurane in class III obesity (2 arms), sponsored by Adriano Teixeira Fernandes. Primary endpoints: Incidence of acute kidney injury, Serum creatinine and 2 more. Started Oct 2010; status: completed.

02

Drugs

propofolsevoflurane
03

Conditions

class III obesity

Beyond the preview

Go deeper on RBR-8wt2fy.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-8wt2fy.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call